Skip to content
Lower risk Medical device recall · FDA · Published May 11, 2026

In2bones NeoSpan SuperElastic Compression Staple: Missing MRI Safety Symbol

In2bones USA recalls NeoSpan SuperElastic Compression Staples due to missing Magnetic Resonance Conditional symbol on packaging and labels. This could lead to unsafe MRI scans if used without proper labeling.

🇺🇸 FDA recall #Z-2355-2026Medical deviceIn2bones ›
Take action

Contact the company

Recalling firmIn2bones USA, LLC7750a Trinity Rd · Cordova, TN 38018-2722
✎ GovInfoNow plain-language explainer

What happened, in plain English

In2bones USA is recalling NeoSpan SuperElastic Compression Staples because the carton, inner tray, and patient labels lack the required Magnetic Resonance Conditional symbol. This means the staples might not be safe for MRI scans, potentially causing injury during medical procedures. Read more at govinfonow.com/recall/49186-in2bones-neospan-superelastic-compression-staple-missing-mri-safety-symbol.

Source Summary by GovInfoNow · govinfonow.com/recall/49186-in2bones-neospan-superelastic-compression-staple-missing-mri-safety-symbol · Updated August 10, 2026 · FDA enforcement record: FDA #Z-2355-2026

Cite this page

“In2bones NeoSpan SuperElastic Compression Staple: Missing MRI Safety Symbol.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/49186-in2bones-neospan-superelastic-compression-staple-missing-mri-safety-symbol. Based on FDA recall #Z-2355-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2355-2026%22&limit=1).

Why it’s dangerous

The missing Magnetic Resonance Conditional symbol means the staples may not be safe for MRI scans. If a patient with these staples undergoes an MRI, the staples could heat up and cause burns or other injuries.

Who’s affected

Medical professionals using these staples for bone fixation procedures are most at risk. Patients undergoing MRI scans after using these staples could face safety issues.

How to tell if you have this one

Check for the product names 'NeoSpan SuperElastic Compression Staple w/Instruments' with catalog numbers T50 SN010, T50 SN012, T50 SN020, T50 SN110, T50 SN115, or T50 SN118. The UDI-DI codes are listed in the recall notice.

  • Brand
    In2bones
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Labels

    Look for the Magnetic Resonance Conditional symbol on the carton, inner tray, and patient label. If missing, the product is recalled.

Where it went and when

Where it was distributed

Distributed in 25 states, and outside the U.S.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: yesIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: yesILWisconsin: yesWIMichigan: not listedMINew York: yesNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: yesNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: not listedCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: not listedNEMissouri: yesMOKentucky: not listedKYWest Virginia: not listedWVVirginia: yesVAMaryland: yesMDDelaware: not listedDEArizona: yesAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: yesOKLouisiana: yesLAMississippi: not listedMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S.: AL, AZ, CA, CO, FL, GA, HI, ID, IL, IN, LA, MD, MO, NC, NJ, NV, NY, OH, OK, PA, TN, TX, UT, VA, and WI O.U.S.: Belgium, Canada, Colombia, France, Ireland, Netherlands, Spain, United Kingdom,” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Alabama, Arizona, California, Colorado, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Louisiana, Maryland, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Tennessee, Texas, Utah, Virginia, Wisconsin.

Recall timeline

FDA published this recall 37 days after the firm started it.

1. Firm started the recall: May 11, 202612. FDA classified it Class II: Jun 8, 202623. Published in FDA’s Enforcement Report: Jun 17, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2355-2026 (May 11, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2355-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA